Stats

P1 FreezeSep8rawSIPproviderdailyTYRA26.73/IRD4.34/INBX114.34. Sep9delayed12:20minutes17.50/4.885;firstpost11UTCopens26.96/4.35arewithinnewsminuteandnotassumedfills. TYRA-34.53%,IRD+12.56%vspriorclose; bothoutcomesretained. INBXonly08:26bar118.01isold,nocurrentreactionclaim. P2 IEXTYRAask0andprior-dayquote;INBX94.6/134.6prior-dayquote;IRD12:29quote4.77/5.08,629.44bps. LiveSIP403. AtIRDask36shares182.88cash,cross-spread11.16 exceedsaccount1%8.5099; smallerlotdoesnotcreateedge. P3 Noindependentcostedclinicalstockruleor15minuteexits; cannotturnTYRAselloffintomeanreversionorIRDriseintomomentumfromoneevent. No newbacktest selected afterseeingoutcome. Cashretained;bounded137collectsprospectivereactionthroughnext13:50review,last20/firstregular5notfullarchive. Sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=TYRA,IRD,INBX&timeframe=1Min&feed=sip&adjustment=raw ; https://runway.adityaperswal.workers.dev/data/stock-snapshots?symbols=TYRA,IRD,INBX&feed=iex . Observations18384–86,18397,18399,18449–51.

Premises:1.Use actual3closedtradepercentageoutcomesfromquery_tradesquantIDs9/7/1; uniformlysample20tradeswithreplacementin20000NumPypaths,seed9091230,compoundhypotheticalfull187.22USD. 2.ResultP&L2.5/50/97.5percentiles[-93.6693,-30.0138,79.1735],loss81.26%. 3.N3alloperatorliquidations makesstationarity/iid/executability unsupported; noresamplingcreatesmissingoutcomes,feesunknownandtradeopportunitiesnotdaily. Thusillustrationcannotpriceclinicaldriftorjustifyrisk; quarterKellyonoriginalmeanpayoffs0andproposednotional0. Correcttodayfundcap187.22 differsprevious245.69cashnote and212.7475accountpositioncap. Noadditionalrisktofund349.01shortfall. Source query_trades fund=quant, observation18398; reproducible core numpy.default_rng(9091230).choice([-0.0539236448052,0.0793994130743,-0.0513049904703],(20000,20)); PnL=(prod(1+r,axis=1)-1)*187.22.

P1 ExactSciPyClopperPearson95%intervals:TYRA8/14primary3mCR28.86–82.34%,8/8singlemarkerORR63.06–100%,9/14bestCR35.14–87.24%. IRD3/4MP19.41–99.37%,5/5anyfunction47.82–100%,0/5SAE0–52.18%. These assume independentBernoullioutcomes, do notadjustmultiplicity,selection,posthoclociorcontrolbias,andarenotapproval/stockwinprobabilities. P2 Ownquery_trades IDs9/7/1 givesSNOW-5.39236%,DELL+7.93994%,GTLB-5.13050%;qtyweightedrealized-1.04605,p1/3,avgwin7.93994,avgloss5.26143,quarterKelly=max(0,.25*(p-(1-p)*loss/win))=0. Alloperatorliquidations before4–6weekhorizon,sooutcomescensoredfororiginalrule; N3not independent clinicalstockholdout. Noinferredstop/targethitrate orslippagewithoutfillbenchmark. Conclusion neither promisingclinicalproportionnorN3tradehistory suppliespositivevalidatededge. Newuntouchedcostedstockeventstudywithexactendpointclassificationwouldmovequalification; singlefavorablequoteornarrativewouldnot. Sources query_trades fund=quant; https://tyrabio.investorroom.com/2026-09-09-Tyra-Biosciences-Reports-Initial-Phase-2-SURF302-Results-Supporting-the-First-Potential-Oral-Innovation-in-LG-IR-NMIBC-with-Dabogratinib ; https://ir.opusgtx.com/press-releases/detail/543/opus-genetics-announces-positive-low-dose-cohort-1-data-from-phase-12-clinical-trial-of-opgx-best1-and-successful-fda-type-c-meeting-with-potential-phase-3-dosing-in-2027 . Calculations archived observation18398/18400/18401.

Numbered premises:1. Supply278.67deployable/account850.99allcash, no holdings/pendingorders perledgerquery. https://runway.adityaperswal.workers.dev .2. Primarymonitorreviews1695/1696 record pricing and guidance but no verifiednew beneficiary accepted netcash sufficient to alter frozenedgegates; observations18365–75 and18392 supply URLs/dates.3. Statistical1697 retainsFROmeanCIcrosszero and no empirical liveaverage loss; otherwatchholdouts remain rejected. https://runway.adityaperswal.workers.dev/data/stock-bars .4. No eligible setup ->approvedquarterKelly0; currentquote cannotrepairhistoricaledge, no newbacktest or trade. ConclusionNoPROPOSE/EXIT/ADJUST/FUND. Valid conclusion under mandate requiring quantified independentnetedge; soundnesslimited by sample selection, issuerbias, missingASPIQ&A,BWENnews403, incompletepolicy/fixturecoverage and15minfills. Startstatecash; goalrepeatablenetprofit; bindingconstraintedge notcapital. Strongestcounterargument: FROpointmeanpositiveandSEIrealoperatinggrowthcouldwork; these deserve prospectivewatches, notbacktestretuning. Changeofmindrequiresindependentvalidatednetstockpayoff plus acceptedmargin/cash and executablecap-compliantwholelot. Due82/85/110/111/123resolved; accepted128next13:50FRO/ASPI/SEI/OESX,130BWEN/131GDSep10,132MaerskOct7,133ASPIquarterend; preservemacro78/49/50/124 andFRO11. Existing5jobscoverofftime,no newjobneeded. Finishingphasebegan12:36UTC (~5.3min elapsed of43plan/45hard); full5minfinishallowanceprotected, no threadexhaustedbudget. Correction: analysis1695 text references observation18376 forSEIturbines; correctrecordID18392.

P1 TYRA Aug31cutoff60mg3monthCR8/14; BOR9/14 andsinglemarkerORR8/8 answerdifferentquestions. RegistryNCT06995677 primaryCR3months,openlabelrandomizeddosecomparison,latestupdatepostedSep9; cannot certify historicalprespecification fromcurrentversion. Safety44,efficacyevaluable26; missing18not failures by assumption. P2 IRD5participants,3BVMD3m/2ARB6m; anyfunction5/5 differsBCVA3/5 andMP3/4. Full36pagesp20/22/26 saylociNOTprespecified; proposedpivotalendpoint>=3dB>=5prespecifiedloci+PROinRCT. p15oneparticipantBCVAworsened. This qualifiesp4summary; futuretrialrequirementandexploratorycohortresults canbothbetrue. NoFDAapprovalorindependentFDAminutes. P3 TYRAJunecash353.944m/Q2loss45.558m=7.769quartersaccountingratio,NOTburnrunway;250mATMcapacitynotproceeds. IRDJunecash88.812m,debt34.932m,warrantliabilities62.145m;Q2operatingloss16.480m versusnet8.098m includes7.174mfairvaluegain. August6runway2029depends onpotentialOberlandfunding,Septembercurrentcashsummarydoesnotverifyunconditionalcash. P4 INBX2PDFs unchanged atdirect12:32check,priorgrade>=3related15/31vs4/34remains. Conclusionprospectiveclinicalwatch,notqualifiedstockdrift. Strongbullcaseconvenientoraltherapy/retinalfunctionimprovement/newregulatorypath isplausiblebutcannotresolvecontrol,selection,durability,financingorstockpayoff. Sponsorsclosesttodatasetbutinterested;release/slidesnotindependentcorroboration. Sources https://tyrabio.investorroom.com/2026-09-09-Tyra-Biosciences-Reports-Initial-Phase-2-SURF302-Results-Supporting-the-First-Potential-Oral-Innovation-in-LG-IR-NMIBC-with-Dabogratinib ; https://d1io3yog0oux5.cloudfront.net/_2f637757c76afd53c5f9cfd976bdd13e/opus/db/601/7992/pdf/BEST1+Cohort+1+Data+Presentation+-+Final+-+9.09.26.pdf ; https://clinicaltrials.gov/api/v2/studies/NCT06995677 ; https://ir.opusgtx.com/press-releases/detail/540/opus-genetics-announces-financial-results-for-second-quarter-2026-and-provides-corporate-update ; https://inhibrx.com/hexagon-slides/ . Observations18376–18401.

Premises:1. Ledgerallcash Supply278.67/account850.99, no open/pendingorders, onlytwo closed operatorliquidations. https://runway.adityaperswal.workers.dev .2. LastcompletedSep8FRO46.62 aboveprior20closehigh46.12/SMA50 40.048 from savedindicators1631, not newly downloaded premarket price; STNG/ASPI didnotmeetcombinedgate. https://runway.adityaperswal.workers.dev/data/stock-bars .3. FRO456 frozen positivepoint unresolved; BWEN749-41.57%N12,GD999-7.44%N7,SEI/OESXnegativeholdouts, ASPI1302-47.66%N24; current primary updates1695–96 do not validate a different strategy.4. Existing simulation1630 (readback, no fresh paths)20kpaths/20trades Beta17.5,24.5 fixedwin/loss gives38.17%lossfrequency at illustrative5/10/25%exposure; omits tails/clustering/15minfills. Conclusion tradeallocation0, no executablequote/limit/stop invented, no new parameter search/backtest. Positioncap212.7475/riskcap8.5099 remain ceilings not allocations. Followup128/130–133accepted, FROdividend11 retained; jobs12/18/36/73/116 alreadycoverinterrun. Actualcollector1495footer15attempted retainsCENTCOM/Bombardierfailures; manualoriginalsrecovered. This is an execution/signal audit using saved research, not a fresh backtest or price forecast.

Startstatecrypto235.86cash, systemequity850.99,zeroopen/queued; goalrepeatablenetprofit; bindingconstraintpositivevalidatedentrypayoff. Numberedpremises:1 Alreadyrecordeddaily/hourly/15minrulesrejected;1698recomputedcashmeans-.637761/-.528767/-.153726%,N82/61/70 andquarterKelly0; no new backtest required to retain rejection.2 Primaryflowreview1699 finds no datednewspotbuy/sale or authorizedLiquidpayout; missingquarterlyquantityandstaleETFCSV remain gaps.3 Livequotes arefresh8/10 but fee/spread hurdles~.53–.62%majors andthinbestquote constrainexecution; zeroentryedge dominatescaps.4 OwnN1operatorliquidation cannot estimate setup payoff. ConclusionNo proposals; noexit/adjustmentwhileflat. Validity: requirededgeabsent implieszeroauthorizedsize. Soundnesslimitedbyhistoricalomissions,costassumptions,unknownsourcepublication/destinations; strongestcounterargument continuingrally accepted as opportunitycost, notnegativepriceprediction. No rule relaxed by349.01shortfall. Existing simulation1652reused as sensitivityonly, notnew forecast. Monitors77/125resolved;129next13:50handoff includesGME;macro45/Arc104/PPI122retained. Jobs133/134/136requestedthrough13:51,14/25preserved; newactualsavedoutputs pending12:36, explicitcollector gaps;135badregexcancelledand136locallyverified. Technical/execution/psychelessonsrecorded. Source https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://runway.adityaperswal.workers.dev/data/crypto-snapshots ; https://www.sec.gov/Archives/edgar/data/1326380/000132638026000050/a991-fy26q2earningsrelease.htm ; https://www.circle.com/transparency ; https://blockstream.info/liquid/api/blocks .

Premises: 1 Frozen1639–1641 daily/hourly/15min holdouts negative; no qualifying rule. 2 Same completed Sep8 daily observation1671 remains aboveSMA100 and RSI2 BTC16.527 ETH40.992 SOL36.248 >frozen10, so intradayquotes cannot be substituted for completed daily signal. No retest/refit this tradingrun. 3 12:32 primary quotes BTC79440.9/79472.08 ETH2503.13/2503.9 SOL104.455/104.576, age1/35.6/57.4s. Assumed25bp credited-asset entry/exit fee plus spread gives recovery hurdles .5413/.5328/.6183%; bestask displayed80.03/83.50/100.19USD below212.7475positioncap. Not full orderbook or fill guarantee. 4 Flat book/noqueued, so no R-progress or exits to adjust. Conclusion no defensible stop/target trade without entry edge. Prior WilderATR14 2257.4264/89.54047/5.056536 are existing range context; no arbitrary new target. Strong counterargument lowercost limit execution could help, but historicalmakerfill/adverseselection evidence missing and family remains rejected. https://runway.adityaperswal.workers.dev/data/crypto-snapshots ; https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://docs.alpaca.markets/us/docs/crypto-fees ; observations18389/18441.

Premises: 1 Sep8 GME release for Aug1quarter remains only current earnings filing: $294.1m digital assets/receivables, $75mQ2loss, $12.4mQ2written-optionproceeds ($18.2m26weeks), no purchase cash. Latest10QJune11 in SEC index checked12:32; release does not identify new spot transactions/counterparty details. 2 IBIT/ETHA CSVs stillSep4 quantities, not matched to Sep8 webpage share issuance; no dated spot flow. 3 Circle sameSep7 USDC net7d+.94bn ($134.286m/day average), unchanged publication; live usdc.com locale/template changes and unparsed date prohibit sequential supply inference. LlamaSep9 has distinct cutoff/population. 4 Liquid tip4051232 age55.733h, secondary failed; operator samepreparationhash. Recipient/reserve598.50016215/3601.47202426BTC; small confirmed tx back to reserve not authorized payout proof. Conclusion update watch, no entry. Closest sources issuer accounting/chain and operator statements each have limits; missing disclosure is not proof of no transactions or delay. Strong counterargument spot transactions may precede disclosure, but cannot time or size that unknown. First order recovery could release trapped claims; second order beneficiaries may sell, hold or hedge; third order prior price reaction and transaction costs could absorb impact. Who benefits: holders/marketmakers and payment issuers, without automatic BTC/ETH cash capture. Sources https://www.sec.gov/Archives/edgar/data/1326380/000132638026000050/a991-fy26q2earningsrelease.htm ; https://data.sec.gov/submissions/CIK0001326380.json ; https://www.ishares.com/us/products/333011/ishares-bitcoin-trust-etf/latest-holdings.csv ; https://www.ishares.com/us/products/337614/ishares-ethereum-trust-etf/latest-holdings.csv ; https://www.circle.com/transparency ; https://www.usdc.com/ ; https://blockstream.info/liquid/api/blocks ; https://x.com/Blockstream . Observations18387–18391.

Trading-run arithmetic check, not a new backtest or new independent samples. Reused recorded costed 2025 training/2026 holdouts1639–1641 and correction1653; Python computed p*average_win-(1-p)*average_loss and max(0,.25*(p-(1-p)/(win/loss))). BTC p42.6829%,win2.642605%,loss3.080586%,N82 => expectancy-.637761%; ETH44.2623/4.139850/4.236197,N61 =>-.528767%; SOL47.1429/4.496455/4.301185,N70 =>-.153726%. Every quarterKelly0. 15m compounded returns -43.5409/-32.9637/-18.7330%; daily/hourly negative also. These unconditional tests do not validate previously rejected pullback family; conditional holdouts only1–5 trades and cost/training failures stay frozen. Own trade history N1 forced liquidation, no setup win/loss or slippage distribution. Premises net positive demonstrated payoff required, absent => zero sizing. Counterexample future prices may rise; these rejected rules are not a bearish forecast. Complete-case omission, serial dependence and assumed cost/quote latency limit generalization. Source https://runway.adityaperswal.workers.dev/data/crypto-bars ; https://docs.alpaca.markets/us/docs/crypto-fees ; query_trades fund=crypto trade10.

Premises:1. Savedbacktest456 fixed next-open20close breakout/1ADRstop/2ADRtarget/5sessions, costedvectorbt and2022–24training/2025–Sep4holdout; priorCLI53 audited and rejected as execution proxy. https://runway.adityaperswal.workers.dev/data/stock-bars .2. Python recalculates17/41p=.4146341463,meanwin5.46270406%,meanloss2.96357664%,expectancy.5302470649%,breakevenp35.1706375%,rawquarterKelly2.42666937%; historical meanCI[-.874362,1.958541]% includeszero. No new trials or parameter sweep.3. Supply tradeledger only2 operator-liquidation wins; under unrealistic IID assumption Wilson95p[34.2380,100]%, empirical average loss undefined; plannedstop/target counts0. https://runway.adityaperswal.workers.dev .4. Existingstat1629 FRO/STNGcorr.78064 andsim1630 conditional20trade lossfrequency38.17% do not validate independent edge. Conclusion approvedKelly0. Selection, correlated trades, regime shift and daily-bar fill uncertainty weaken soundness of point estimates. Counterexample positive expected payoff may be real; require prospective independent net evidence rather than infer certainty from live2/2. Retain frozen train/holdout and no redundant rebacktest during trading run.

Premises:1. Maersk Sep9 Nordic surcharge0–20% explicitly responds to fuel costs, EV/rail excluded; exact paid bases unknown. https://www.maersk.com/news/articles/2026/09/08/emergency-inland-fuel-energy-surcharge-nordic-region .2. Oct8 ECSA surcharge500/1000USD per dry box has distinct spot/FMC/nonFMC calculation dates, so announcement does not identify payable cash. https://www.maersk.com/news/articles/2026/09/08/pss-east-coast-south-america-west-coast-caribbean-us-gulf .3. CENTCOM claims fiveSep8 ships destroyed, separatelythreeSep5; belligerent source lacks replacement-fixture evidence. https://www.centcom.mil/MEDIA/PUBLIC-RELEASES/Article/4593050/us-destroys-5-irgc-tankers-after-iran-targets-another-american-warship/ .First order: fuel/route disruption raises shipper gross charges; rights sellers receive equipment-access cash. Second: fuel suppliers, insurers and equipment vendors may absorb the premium while customers substitute rail/EV or reduce cargo. Third: eventual capacity additions and lost demand can compress scarcity value before equity holders earn it. Aircraft restrictions can redirect demand only if GD has deliverable slots; integrated US suppliers can also lose sales. Counterexample profitable protected contracts can yield durable margins, but no new paid incremental figure established in bounded review. These are conditional causal chains, not forecasts or separately independent reports. Allocationzero.

Premises:1. SEI paid131.2m for turbine rights/milestones and owes364.9m fixed supplier payments plus up to130.2m conditional assignment consideration; record18376 and original https://ir.solaris-energy.com/~/media/Files/S/Solaris-IR/reports-and-presentations/10-q-2q26.pdf .2. Sep8 EBITDA raise includes acquisitions, so +36.1446% H2 midpoint does not isolate organic rents. https://ir.solaris-energy.com/news/2026/09-08-2026-114509510 .3. OESX repeat order lacks exact margin/accepted cash; customer praise is issuer-relayed. https://investor.oriones.com/news-releases/news-release-details/orion-announces-additional-multimillion-dollar-data-center .4. BWEN latest all-form amendment is2025Manitowoc proforma, not Sep2026lease-end proof;17.154m sale cash and8.990m discontinued liabilities are June-vintage. https://www.sec.gov/Archives/edgar/data/1120370/000143774926028689/bwen20260820_8ka.htm ; https://www.sec.gov/Archives/edgar/data/1120370/000143774926027061/bwen20260630_10q.htm .5. Bombardier footprint statement and ASPI operational plan give no verified incremental GD delivery profits or September helium receipts. https://www.globenewswire.com/news-release/2026/09/08/3357281/0/en/bombardier-statement.html ; https://ir.aspisotopes.com/news-events/press-releases/detail/119/asp-isotopes-hosts-inaugural-capital-markets-day-and .Conclusion: retain fundamental watches, approvedsize0. Validity: positive operating claims do not imply a validated stock payoff. Soundness limited by issuer bias, inaccessible BWENnews/ASPIQ&A and unverified current cash. Strong counterargument: secured fixed-price supply and customer prepayments can finance valuable growth; would upgrade fundamentals with accepted profitable deliveries, but still require independent net stock edge. No claim that growth capex is inherently uneconomic.

Startcash49.14, no own holdings orqueuedorders perqueriedledger; goalrepeatablepre-event gains. Bindingconstraint credible netactual-windowedge, not equity or month-endshortfall. Premises1 primarycalendar1691–93 verifies17domestic earnings rows acrossSep9/10 plusInditex alreadyreleased, clinicalTYRA/IRD andTLXSep11riskboundary; calltimesarenotfirstnews. 2 LOVE final-session timeonly1676positive14.87%N10 butCIcrosses0, concentration1681 andrequiredexits1677-0.3685%/stress-2.3414%;2ADR1678+.28%stressstilluncertain. Notfreshindependentholdout afterissuer/periodselection.3 Technical1686,indicators1687,MC1682 cannotfixfailedgates. Kellyunitcorrection1685supersedes earliercashinterpretation; adoptedsize0. 4 Fundamental1638 InditexCFimprovesbutWCandleasebridge matter; pre-eventwindowalreadypast. Consequences1689keep conditionalbeneficiaries separatefrompriceedge. Own3losses includetwooperator-censoredhorizons, no observedwinner. Strongcounterargumentpositivecash/time-onlyreturns deservesnewresearch, notdeleteoutlierortradeunstopped. ConclusionnoPROPOSE/EXIT/ADJUST/FUND, no live stopsneeded. What changesmind: independent notice-aware actual-window coststressededge withpositive lowerconfidencebound, executablequotes andcash/risklimits; currentbeat/strongtape/shortfallalone insufficient. Monitor19resolved;126SAIL/CNM/KFY12:30armed,CHWY12/ASO32andothersretained. Fivejobcapblockednewcollector; tested80→132preservescoverage,actual08:15:56exit0/full1569bytefooter, next12:15:44before12:30. NewcombinedSep10nativealertrejected20cap, journalhandoffretained; aftermorning126resolvedarm successor. Sources: https://investor.lovesac.com/news-events/press-releases/detail/166/the-lovesac-company-announces-second-quarter-conference ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all ; Inditexprimary in1638; fullcalendarprimaryURLs1691–93 and local /tmp/codex-run-F7wXOo/preopen-plan.md. Sourceauditcut at12minallowance: DSGX/small-namecompleteness,exactDOLclaimsnextrelease,fullFDAfirstnewstiming/quotehistory remainnamedgaps. Mainworkfinished~15min, last5reservedforrecords/report; finish~20minunder42planned/45hard. Lessons513–515 saved.

Premises1 no new primary-confirmed Sep9/10 PDUFA decision found in bounded search; not a claim none exist. TLX Pixclara Sep11 goal may produce early news: https://telixpharma.com/news-views/fda-accepts-nda-for-tlx101-px-pixclara/ ; latest RSSSep1, no current entry. TYRA Sep9 08ET SURF302 clinical call https://tyrabio.investorroom.com/2026-09-04-Tyra-Biosciences-to-Host-Conference-Call-on-Initial-Results-of-Oral-Dabogratinib-from-the-SURF302-Phase-2-Study-for-IR-NMIBC-on-September-9%2C-2026 andIRD Sep9 08ET OPGx-BEST1 call https://ir.opusgtx.com/press-releases/detail/542/opus-genetics-to-present-opgx-best1-cohort-1-clinical-data-in-investor-webcast-and-at-upcoming-leading-ophthalmology-conferences are not approval deadlines or guaranteed first-news times; quant47/48 alreadycover, no cross-fund resolution. Positive full-population safety/efficacy -> record and require validated strategy; adverse/absent -> cash/reverify. 2 BLS https://www.bls.gov/schedule/2026/home.htm Sep9 10ET JuneECEC, Sep10 08:30ET AugustPPI; CPI Sep11. Census https://www.census.gov/economic-indicators/calendar-listview.html Sep9 10ET Q2services andSep10 10ET Julywholesale. EIA https://www.eia.gov/outlooks/steo/outlook.php SeptemberSTEO dateSep9, hourunknown; https://www.eia.gov/petroleum/supply/weekly/schedule.php weeklypetroleumSep10 noonET dueholiday. ECB https://www.ecb.europa.eu/press/calendars/weekly/html/index.fr.html Sep10decision14:15CET/press14:45CET asprinted; keep timezone label explicit rather than assumeUTC conversion. Joblessclaims exactnext-release agencycalendar notconfirmed; currentDOLpdfSep3 isnotSep10confirmation. 3 Benign costs/strong activity improve prospective context; adverse mix weakens it; neither proves stock returnedge. FDA townhalls/comment deadlines are not product decisions. ExistingcryptoArcSep16 outsidewindow, no separate qualified crypto catalyst established. Research scope spans issuers/sectors/Europe; no venue/FX assumptions or new fund proposal. Calendar thread cut at allowance with DSGX/small-name coverage and agencyclaims gaps named.

Premise1 call times are distinct from first news; exact release minutes are unverified unless stated. Premise2 no independently validated new actual-window edge, so no automatic purchases in either outcome branch. All rows rechecked Sep9~08UTC; ASO direct403 retains prior verified source and explicit gap. Source rows: LOVE: Before open; call08:30ET. Issuer 2026-08-27. https://investor.lovesac.com/news-events/press-releases/detail/166/the-lovesac-company-announces-second-quarter-conference MCFT: Before open; call08:30ET; overrides aggregator after-close error. Issuer 2026-08-24. https://investors.mcbh.com/news/news-details/2026/MasterCraft-Boat-Holdings-Inc--to-Webcast-Fiscal-Fourth-Quarter-and-Full-Year-2026-Earnings-Conference-Call-Thursday-September-10-2026/default.aspx CAL: Before open; call10:00ET. Issuer 2026-08-19. https://investor.caleres.com/news/news-details/2026/Caleres-to-Announce-Second-Quarter-2026-Results-on-September-10/default.aspx M: Call08:00ET; announcement gives date but not exact release minute. Issuer 2026-08-19. https://www.macysinc.com/newsroom/news/news-details/2026/Macys-Inc--to-Report-Second-Quarter-2026-Results-on-September-10-2026/default.aspx CPRT: After16:00ET; call17:30ET. Issuer 2026-09-01. https://www.copart.com/content/us/en/press-releases/copart-to-release-fourth-quarter-2026-results ORCL: After close; call16:00Central. Issuer 2026-09-02. https://investor.oracle.com/investor-news/news-details/2026/Oracle-Sets-the-Date-for-its-First-Quarter-Fiscal-Year-2027-Earnings-Announcement/default.aspx ADBE: Call14:00Pacific; exact first release minute unverified. Issuer retrieved2026-09-09. https://www.adobe.com/investor-relations.html ZUMZ: After close; call17:00ET. Issuer 2026-08-27. https://www.globenewswire.com/news-release/2026/08/27/3352391/0/en/zumiez-inc-to-report-fiscal-2026-second-quarter-results.html If operating demand, margins and cash improve: record prospective evidence and require independent costed validation. If deterioration, early announcement, rescheduling or absent results: retain cash, verify issuer and preserve failure observations. Flat book; no stops needed. This is a bounded verified watchlist, not an exhaustive whole-market calendar. Smaller unverified aggregator names and DSGX primary-date gap remain; no guessed dates. Morning monitor126 complementsCHWY12/ASO32; later new dates in handoff notes where20monitor cap binds.

Premise1 call times are distinct from first news; exact release minutes are unverified unless stated. Premise2 no independently validated new actual-window edge, so no automatic purchases in either outcome branch. All rows rechecked Sep9~08UTC; ASO direct403 retains prior verified source and explicit gap. Source rows: CHWY: Before open; call08:00ET. Issuer 2026-08-19. https://investor.chewy.com/news-and-events/news/news-details/2026/Chewy-Announces-Fiscal-Second-Quarter-Financial-Results-Conference-Call/default.aspx ASO: Before open; call10:00ET; prior primary confirmation, direct recheck403. Issuer 2026-08-26. https://investors.academy.com/news-releases/news-release-details/academy-sports-outdoors-announces-second-quarter-fiscal-2026 SAIL: Before open; call08:30ET. Issuer 2026-08-13. https://investor.sailpoint.com/news-releases/news-release-details/sailpoint-announces-date-fiscal-second-quarter-2027-earnings CNM: Before open; call08:30ET. Issuer 2026-08-26. https://coreandmain.com/news/core-and-main-to-announce-fiscal-2026-second-quarter-results/ KFY: Before open; call12:00ET. Issuer 2026-09-02. https://www.kornferry.com/about-us/press/korn-ferry-to-report-quarterly-earnings-via-live-webcast-on-september-9-2026 SIG: Primary event page confirms08:30ET call; first release time not reverified. Issuer retrieved2026-09-09. https://www.signetjewelers.com/investors/presentations-and-events/event-details/ AVAV: After close; call16:30ET. Issuer 2026-08-26. https://www.avinc.com/2026/08/26/aerovironment-inc-to-announce-first-quarter-of-fiscal-year-2027-earnings-and-host-conference-call/ NAVN: After close; call17:00ET. Issuer 2026-08-26. https://investors.navan.com/node/8791/pdf WLTH: Call17:00ET; exact first release time not reverified. Issuer 2026-08-19. https://ir.wealthfront.com/ If operating demand, margins and cash improve: record prospective evidence and require independent costed validation. If deterioration, early announcement, rescheduling or absent results: retain cash, verify issuer and preserve failure observations. Flat book; no stops needed. This is a bounded verified watchlist, not an exhaustive whole-market calendar. Smaller unverified aggregator names and DSGX primary-date gap remain; no guessed dates. Morning monitor126 complementsCHWY12/ASO32; later new dates in handoff notes where20monitor cap binds.

Start:quant245.69USDcash,account850.99USD,zeroopen/pending/closingreverified. Goalrepeatablepositive netreturns; bindingconstraintvalidatedexecutableedge. P1.PagonidisoriginalIBSpaperprovidesdistinctdailyclose-locationmechanism; ourcashlongnextopenadaptationcannotinheritclose-to-closepaperreturns. Preregistered1431beforedata; eightfixedUS/internationalETFs,2016–20training,2021–25holdout,2026extension,all696cellsretained. P2.EEMmainholdout252trades−21.6318%,DD25.2062%,cashmean−.0943565%,95%monthlyblockCI[−.170316,−.008138]%;stress−52.6571%,Kelly0. All8mainholdouts/all72stresscellslose. Grossmean+.0256023%hasCIincludingzero;one-wayzero-feebreakevencostpointestimate1.27995bpsnotvalidatedexecution. P3.2026base+2.3118%/28tradesbecomes−3.2602%understress; neitherpositiveextensionnorcurrentEFA/EWJ/EWZ/SPYsignalsrescuefailedfamily. P4.Wholelots/PDT/15minexitsnotvalidated;max4same-daytradesin5sessionsand12overlappingwindowsabovevenue3cap.648rulecellsand48buyholds independentlyreconciled. Dailygreenpartialvariant−33.7468%isconservativeambiguousOHLC,not15minfills. P5.ClinicalunchangedfullPDFsandfreshInditexcashbridge1672offerprospectiveresearch,notvalidatedequitydrift. ConclusionnoPROPOSE/EXIT/ADJUST/FUND;retaincash. Valid undermandatedqualification; soundnessconditionalonprovideradjusteddataandmodel,cannotrejectallIBS/quanttradinguniversally. Strongestcounterargumentcheaperexecution/trueovernightedge: require independent historical execution andnewuntouchedwindow,notretuning. Next12:30UTCpreopen: originalTYRA/IRDreleaseandslides,INBX121fullfilesandjobs84/131,earningsfirstnews;calendar1675coversSep9–10andexplicitFDAgap.117resolved;131replacesunrun130andexpired119,actual08:15outputunchangedbothPDFs,4remaining09:15–12:15. Preserve15/84/85and47/48/60/42;newPPI127reviewSep10 13:50UTC. Monitorsresearchonly,noneauthorizesorders. Code1443–1447readbackexact; allmetricsobservations18126–18274 plusdiagnostics; lessons510–512. Finalrecordingphasebegan~14min,finishunder20minwithin43plan/45hard; nounfinisheddependenttest. Gaps:15minfill/PDTthrottled/rawcashdividendvalidation,exhaustiveFDAcalendar,firstpublicminuteofInditex,TXNMdeadlineonlypriorverification; allocationzerowhileunresolved. Sources https://www.naaim.org/wp-content/uploads/2014/04/00V_Alexander_Pagonidis_The-IBS-Effect-Mean-Reversion-in-Equity-ETFs-1.pdf ; https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all ; https://inhibrx.com/hexagon-slides/ ; https://www.bls.gov/schedule/2026/09_sched.htm .

Premises1 Inditex H1 demand/sales and cash improved but workingcapital outflow reduced783m andinventory grew9.319%, so earnings alone do not identify repeatable cash. Source https://www.inditex.com/itxcomweb/api/media/cca26fd1-a685-41d6-82d4-10b3f30428f4/1H2026Results.pdf?t=1788937488685 . Premise2 existing LOVE1104 June11 source https://investor.lovesac.com/news-events/press-releases/detail/164/the-lovesac-company-reports-first-quarter-fiscal-2027 hasQ2EBITDAguide-4to+2m including3.6mrefund expectedrecognition; future result needs recurring margin/cash bridge, not headline comparison alone. First order (conditional): firm sell-through and controlled markdowns support retained grossprofit; tariffs/freight or promotions can absorb it. Second order: inventory, supplier payment timing and lease/capex commitments determine how much converts to distributable cash; suppliers or landlords may capture gains. Third order: durable cash can fund investment/buybacks and alter competitive position, but the stock may already price it, so positive fundamentals need not produce a positive pre-event entry. Who benefits: shareholders only if incremental cash remains after obligations; customers from value offers, suppliers from paid volumes. Strongest counterargument Inditex demonstrates cash can improve despite difficult conditions; reject uniform retail bearishness. Facts end at issuer period disclosures; no causal supplier estimate or forecasted payoff. Upcoming M/CAL/MCFT/ZUMZ have distinct businesses; do not transfer LOVEodds mechanically. No extra fund proposal.

Ran required CLI: node /app/agent/dist/backtest.js --symbols LOVE --strategy momentum --lookback 20 --days 730 --stop-pct 5 --target-pct 10 . It returns501dailybars,56trades,return-17.85047%,DD44.98827%,win32.14286%,meantrade-.164327%,buyhold-22.94455%. Premise1 this generic unsplit no-fee momentum rule is not an earnings-specific holdout. Premise2 negative gross diagnostics cannot validate current allocation. Conclusion do not trust screen; actual selected chronological event experiment1676–78 uses fees/slippage, full15min marks and independent reconciliation. FirstCLIoutput was display-truncated, exact rerun saved love_cli.json to verify N56; numerical totals unchanged. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE&timeframe=1Day&feed=iex .

Premises1 primary event still pending, exact tested entry window, independent positive costed expectancy, executable risk and capital constraints must all pass. 2 LOVE final-session diagnostics: trendpositiveN6 mean.026658%, momentumpositiveN5 mean.019224%, markettrendpositiveN7 mean-.219100%; opposite groups positive but selected tiny samples, not an optimized filter. Current SPY765.96>SMA50 757.5966 whileLOVE belowSMA50 and20momentumnegative. This combination is not an independently validated conditional edge. All6fixedgroup figures observations18337–18342. 3 TLX/CPRT stronger tape cannot repair FDA first-news risk or a failed/missed earnings window. 4 Time-only LOVE meanCI crosseszero and fixed mandatory exits deteriorate; therefore no PROPOSE even though whole shares affordable. Strongcounterexample future independent event cohort could establish positive expectancy; do not infer all run-ups fail. No new parameter search. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all and daily panels18292–18299; primary upcoming source https://investor.lovesac.com/news-events/press-releases/detail/166/the-lovesac-company-announces-second-quarter-conference .

Premise1 completed Sep8 SIP adjusted bars,89each: LOVE16.07 belowSMA20 16.47025/SMA50 16.9366,20session-7.10983%,ADR20.655065 and simpleATR14.693036. MCFT23.53/M22.45/CAL12.03/ZUMZ17.70 all below20/50SMA withnegative20momentum; wholecapacity2/2/4/2 respectively beforefees at49.14fundcap. These are context, not a profitable bearish or mean-reversion signal. Premise2 LOVE one-range stop anchored hypothetically at Sep8close would be15.414935 and1.5range target17.052598; this is a paper geometry, not live order levels or executable entry. Actual entry changes levels; marginal costs reduce gross1.5reward/risk. The matching mandated-exit study1677 loses0.3685%,stress2.3414% over10events. Stop checks15min, not guaranteed touches. Premise3 CPRT32.60 is stronger,+10.1724%20sessions, but prior actual T3 rule113 was rejected and its entry window elapsed. TLX11.98 is above20/50SMA but Sep11 deadline does not protect Sep9/10 from early decision or other pipeline news. No overnight biotech proposal. All observations18292–18299 includevolume/ranges/means and source. Nominal1%equityrisk8.5099/fund49.14/maxvenue212.7475 are ceilings, not reason to deploy. Source https://runway.adityaperswal.workers.dev/data/stock-bars?timeframe=1Day&feed=sip&adjustment=all . No current bidask or limit fill assumed; no live stops to adjust while flat.

Correction to new final-session records1676–78 and1682, observations18280–18291: their field quarterKelly=p-(1-p)/(W/L), divided4, is in loss-risk units. It is NOT the fraction of cash to invest when average fractional loss L is less than1. The statement in1682 multiplying.0439428 directly by49.14 to obtain a permissible~2.16USD position is withdrawn. For binary averages W,L expressed as fractional asset returns, capital fraction is f=(p/L-(1-p)/W)/4, equal to risk-unit fraction/L; then apply cash, venue, fund and nominal-risk caps. This binary approximation also ignores the full return distribution and is not a validated allocation. Reproducible love_test.py and summary JSON now name risk_unit_quarterKelly, capital_quarterKelly and operational_fraction separately. All returns, drawdowns, bootstrap CIs and Monte Carlo paths remain unchanged. Actual allocation stays0 because uncertainty, selected history, mandatory exits and executable quote gates fail; positive point sizing cannot repair these conditions. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=LOVE,SPY&timeframe=15Min&feed=sip&adjustment=all . Apply this unit check to future studies rather than copying older journal terminology.

Chain1: temporaryUS-sessionETFsellingmaydepressclose; thenforeignmarketsreopenanddealersarbitragerevisedvalues; thenpartofthereboundarrivesbeforeUSnextopen. Liquidityproviders maybenefit, butpersistentcountry/FXinformationcaninsteadextendthedecline. OurEEMovernight+.02953%andnextsession+.04656%grosslogreturns areconsistentwithpartialovernightresponse, notcausalproof. Costsandweakmodernpremiumdefeattradableadaptation. Chain2: strongerInditexsalesandlessworkingcapdrainincreasecash; theninventorygrowth+9.32%requirescontinuedconversion; thenreversingsupplierterms/inventoryaccumulationcanweakenfutureFCFdespitegoodrevenue. Shareholdersandvendorsmaybothbenefit,butretailerFCF+97.34%isnotarun-rateforecast. Chain3: favorableclinicaltoplineattractsattention; thenfullITT/safetyhierarchycanqualifyapparentbenefit; thendevelopmentcosts,dilutionandregulatorytimelinecanoffsetequitydrift. Issuersbenefitfromfinancinginterest, marketmakersfromspreads; firstnewsandcallsaredifferent. Strongestcashcounterargument:cheaperexecutionpluspositivegross/recentIBSmaywork. Rewriteclaimnarrowly: grossCIspanszero,all72stresscellslose,2026EEM+.2.3118%turns−3.2602%understress; rejectthisfamilyratherthanclaimuniversalinefficiencyabsence. Funding349.01USDneeddoesnotalterpayoutdistributionorquarterKelly0. Sources https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all ; https://www.cnmv.es/webservices/verdocumento/ver?t=%7Bfd6314ae-a7a5-44fe-9edb-5cafcb617c95%7D ; https://inhibrx.com/hexagon-slides/ .

Premises:1.Sep8completedOHLC givesIBS<=.2forEFA/EWJ/EWZ/SPY; EEM.2716nottriggered. Other3fixedcontrolsFXI.3333,IWM.2228,QQQ.4417nottriggered. Allprimarycostedholdoutsnegative, so signalalonecannotenter. 2.CloseEEM68.83 permits3whole206.49USD; EFA107.76only1shareundercap, EWJ97.96allows2,EWZ38.61allows5; SPY765.96 exceeds212.7475. Affordabilitydoesnotjustifyallocation. EEMprior20ADR.67089impliesabout2.01267USD3share1ADRnominalrisk, buthypotheticalrangelevelisnotcurrentorderrecommendation. 3.Main252trades allsame-session; max4signalsin5sessions and12overlappingwindowsabove3 exceedcurrentvenueallowance; historicalreturndoesnotapplyPDTthrottle. 4.Greenhalf+1ADR/BEaveragedfill sensitivity loses33.7468%, opencloseonlyloses16.8954% versusmanaged21.6318%loss. Green31partialBEexitsareconservativeambiguousdailyordering: low<=openbydefinition, so cannotdeterminewhetherBEwouldhitafterprofittaking. No15minstopmonitoring, closingtimeorderexecutionorwholelotpartialhistoryvalidated. All696vectorbtportfolioreturnsreconcileindependentcashproductsandclosedtradecounts; DDmarksatmodeledopen/exitomitintradayrisk. Conclusionnofreshquotesorlimit/stoppricesrequestedforfailedrules; requireindependentexecutionvalidationbeforerisk. Source https://runway.adityaperswal.workers.dev/data/stock-bars?symbols=SPY,QQQ,IWM,EEM,EFA,EWJ,EWZ,FXI&timeframe=1Day&feed=sip&adjustment=all